Arrhythmia Research Technology (HRT) Reports Q2 EPS of $0.02
Tweet
Share
E-mailGet Alerts HRT Hot Sheet
Price: $14.36 --0%
Financial Fact:
Weighted Average Number of Shares Outstanding, Diluted: 2.82M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Weighted Average Number of Shares Outstanding, Diluted: 2.82M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Arrhythmia Research Technology (NYSE: HRT) reported Q2 EPS of $0.02, versus $0.04 reported last year. Revenue for the quarter came in at $5.13 million, versus $5.66 million reported last year.
For earnings history and earnings-related data on Arrhythmia Research Technology (HRT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
